Literature DB >> 9801349

O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry.

A Cloeckaert1, V Weynants, J Godfroid, J M Verger, M Grayon, M S Zygmunt.   

Abstract

Smooth Brucella strains are classified into three serotypes, i.e., A+M-, A-M+, and A+M+, according to slide agglutination with A and M monospecific polyclonal sera. The epitopes involved have been located on the O-polysaccharide (O-PS) moiety of the smooth lipopolysaccharide (S-LPS), which represents the most exposed antigenic structure on the surface of Brucella spp. By use of monoclonal antibodies (MAbs) a number of epitope specificities on the O-PS have been reported: A, M, and epitopes shared by both A and M dominant strains, which have been named common (C) epitopes. The latter have been further subdivided, according to relative MAb binding in enzyme-linked immunosorbent assays (ELISA) to A- and M-dominant Brucella strains and to cross-reacting Yersinia enterocolitica O:9, into five epitopic specificities: C (M>A), C (M=A), C/Y (M>A), C/Y (M=A), and C/Y (A>M). In the present study, we studied the occurrence of these epitopes at the surface of representatives of all Brucella species and biovars including the live vaccine strains by analyzing the levels of MAb binding to whole Brucella cells in ELISA and flow cytometry assays. In ELISA, the level of MAb binding correlated well with the previously defined epitope specificity and the serotype defined by polyclonal sera for each Brucella species, biovar, or strain. However, MAbs to the C (M=A) and C (M>A) epitopes showed insignificant binding to B. suis biovar 2 strains and bound at lower titers to B. suis biovar 3 and B. neotomae than to the other Brucella strains. Some of the flow cytometry results were contradictory to those obtained by ELISA. In fact, it appeared by flow cytometry that all O-PS epitopes, including the A and M epitopes, are shared to different degrees by Brucella spp. which nevertheless show a high degree of O-PS heterogeneity according to MAb binding intensities. The subdivision of MAb specificities and Brucella serotypes was therefore less evident by flow cytometry than by ELISA. Whereas in ELISA the MAb specific for the A epitope showed insignificant binding to Y. enterocolitica O:9, this MAb bound strongly to Y. enterocolitica O:9 in flow cytometry. One of the two MAbs specific to the C (M=A) epitope also bound at a low but significant level to B. suis biovar 2 strains. However, as in ELISA the MAb specific for the C (M>A) epitope did not bind at all to B. suis biovar 2 strains in flow cytometry. Flow cytometry provided new information regarding specificity of the MAbs and may further explain some aspects of the capacity of passive protection of some MAbs against smooth Brucella infection in mice. As shown in the present study the occurrence of Brucella strains apparently completely devoid of one specific C O-PS epitope (e.g., B. suis biovar 2 devoid of the C [M>A] epitope) offers the possibility of obtaining vaccine strains devoid of a diagnostic O-PS epitope, which could further help to resolve the problem of discriminating infected from vaccinated animals that remains a major goal in brucellosis research.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9801349      PMCID: PMC96216          DOI: 10.1128/CDLI.5.6.862-870.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  44 in total

1.  Monoclonal antibodies and characterization of epitopes of smooth Brucella lipopolysaccharides.

Authors:  I Greiser-Wilke; V Moennig
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Sep-Oct

Review 2.  Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine.

Authors:  X Xin
Journal:  Vaccine       Date:  1986-12       Impact factor: 3.641

3.  Characterization of monoclonal antibodies against Brucella melitensis.

Authors:  I Greiser-Wilke; V Moennig; D Thon; K Rauter
Journal:  Zentralbl Veterinarmed B       Date:  1985-09

4.  Immunity conferred upon mice by anti-LPS monoclonal antibodies in murine brucellosis.

Authors:  J Limet; A M Plommet; G Dubray; M Plommet
Journal:  Ann Inst Pasteur Immunol       Date:  1987 May-Jun

5.  Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies.

Authors:  J A Montaraz; A J Winter; D M Hunter; B A Sowa; A M Wu; L G Adams
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

6.  Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice.

Authors:  A J Winter; G E Rowe; J R Duncan; M J Eis; J Widom; B Ganem; B Morein
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

7.  Serological confirmation of Brucella abortus and Yersinia enterocolitica O:9 O-antigens by monoclonal antibodies.

Authors:  D R Bundle; M A Gidney; M B Perry; J R Duncan; J W Cherwonogrodzky
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Evidence of heterogeneity of lipopolysaccharides among Brucella biovars in relation to A and M specificities.

Authors:  G Dubray; J Limet
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Jan-Feb

9.  Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9.

Authors:  M Caroff; D R Bundle; M B Perry
Journal:  Eur J Biochem       Date:  1984-02-15

10.  Use of monoclonal antibodies to identify the distribution of A and M epitopes on smooth Brucella species.

Authors:  J T Douglas; D A Palmer
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

View more
  19 in total

1.  Monoclonal Antibody-Defined Specific C Epitope of Brucella O-Polysaccharide Revisited.

Authors:  Michel S Zygmunt; David R Bundle; N Vijaya Ganesh; Julie Guiard; Axel Cloeckaert
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

2.  Evaluation of indirect enzyme-linked immunosorbent assays and IgG avidity assays using a protein A-peroxidase conjugate for serological distinction between Brucella abortus S19-vaccinated and -infected cows.

Authors:  Ana C A M Pajuaba; Deise A O Silva; José R Mineo
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

3.  New Features in the Lipid A Structure of Brucella suis and Brucella abortus Lipopolysaccharide.

Authors:  Adriana C Casabuono; Cecilia Czibener; Mariela G Del Giudice; Ezequiel Valguarnera; Juan E Ugalde; Alicia S Couto
Journal:  J Am Soc Mass Spectrom       Date:  2017-09-18       Impact factor: 3.109

4.  Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge.

Authors:  Dina Moustafa; Virendra K Garg; Neeta Jain; Nammalwar Sriranganathan; Ramesh Vemulapalli
Journal:  Vaccine       Date:  2010-11-23       Impact factor: 3.641

5.  Lipopolysaccharide heterogeneity in the atypical group of novel emerging Brucella species.

Authors:  Michel S Zygmunt; Isabelle Jacques; Nelly Bernardet; Axel Cloeckaert
Journal:  Clin Vaccine Immunol       Date:  2012-07-03

6.  Efficacy of several serological tests and antigens for diagnosis of bovine brucellosis in the presence of false-positive serological results due to Yersinia enterocolitica O:9.

Authors:  P M Muñoz; C M Marín; D Monreal; D González; B Garin-Bastuji; R Díaz; R C Mainar-Jaime; I Moriyón; J M Blasco
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

7.  Antigenic, immunologic and genetic characterization of rough strains B. abortus RB51, B. melitensis B115 and B. melitensis B18.

Authors:  Rosanna Adone; Michele Muscillo; Giuseppina La Rosa; Massimiliano Francia; Michela Tarantino
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

8.  Development of an improved competitive ELISA based on a monoclonal antibody against lipopolysaccharide for the detection of bovine brucellosis.

Authors:  Xiaolei Wang; Yan Wang; Limei Ma; Ran Zhang; Yanyan De; Xiaowen Yang; Chuanqing Wang; Qingmin Wu
Journal:  BMC Vet Res       Date:  2015-05-21       Impact factor: 2.741

Review 9.  When the Going Gets Rough: The Significance of Brucella Lipopolysaccharide Phenotype in Host-Pathogen Interactions.

Authors:  Lauren W Stranahan; Angela M Arenas-Gamboa
Journal:  Front Microbiol       Date:  2021-07-15       Impact factor: 5.640

10.  The epitopic and structural characterization of Brucella suis biovar 2 O-polysaccharide demonstrates the existence of a new M-negative C-negative smooth Brucella serovar.

Authors:  Mona V Zaccheus; Tara Ali; Axel Cloeckaert; Michel S Zygmunt; Andrej Weintraub; Maite Iriarte; Ignacio Moriyón; Göran Widmalm
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.